Extending Expiration Dates of Doxycycline Tablets and Capsules in Strategic Stockpiles: Guidance for Government Public Health and Emergency Response Stakeholders

Source: U.S. Food and Drug Administration (FDA). Published: 4/2019. This 22-page document provides final guidance to government stakeholders on testing to extend the expiration date —under section 564A(b) of the Federal Food, Drug, and Cosmetic (FD&C) Act —of stockpiled doxycycline tablets and capsules for public health emergency preparedness and response purposes for an anthrax emergency. It applies to both doxycycline monohydrate and doxycycline hyclate tablets and capsules equivalent to 50 mg and 100 mg of doxycycline that are indicated for post -exposure prophylaxis (PEP) or treatment of inhalational anthrax. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news